Skip to main content
Top
Published in: Clinical Rheumatology 1/2007

01-01-2007 | Case Report

Successful treatment of pediatric systemic polyarteritis nodosa with cholestatic hepatitis

Authors: Han-Jung Park, Yong-Jun Choi, Jeong-Eun Kim, Young-Min Ye, Hae-Sim Park, Chang-Hee Suh

Published in: Clinical Rheumatology | Issue 1/2007

Login to get access

Abstract

Polyarteritis nodosa (PAN) is a rare vasculitis in children. We report a case of 5-year-old boy with systemic PAN and cholestatic hepatitis. He had fever, abdominal pain, and gastrointestinal bleeding. Angiography revealed multiple microaneurysms in the renal, hepatic, and superior mesenteric arteries. Clinical manifestations improved slowly after immunosuppressive therapy, but liver enzyme and bilirubin levels elevated gradually. Liver biopsy findings revealed marked centrizonal canalicular cholestasis, bile duct damage, and intact hepatocyte, but there was no evidence of viral hepatitis or vasculitis. Levels of liver enzymes and bilirubin improved after two cycles of cyclophosphamide therapy. We thought that the possible etiology of elevated liver enzyme and bilirubin levels might be a manifestation of PAN.
Literature
1.
go back to reference Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al (1994) Nomenclature of systemic vasculitides. Arthritis Rheum 37:87–92CrossRef Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al (1994) Nomenclature of systemic vasculitides. Arthritis Rheum 37:87–92CrossRef
2.
4.
go back to reference Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR (2002) Incidence of Henoch–Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360:1197–1202CrossRefPubMed Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR (2002) Incidence of Henoch–Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360:1197–1202CrossRefPubMed
5.
go back to reference Ozen S, Anton J, Arisoy N, Bakkaloglu A, Besbas N, Brogan P et al (2004) Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr 145:517–522CrossRefPubMed Ozen S, Anton J, Arisoy N, Bakkaloglu A, Besbas N, Brogan P et al (2004) Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr 145:517–522CrossRefPubMed
6.
go back to reference Bakkaloglu A, Ozen S, Baskin E, Besbas N, Gur-Guven A, Kasapcopur O et al (2001) The significance of ANCA in microscopic polyangiitis and classic polyarteritis nodosa. Arch Dis Child 85:427–430CrossRefPubMed Bakkaloglu A, Ozen S, Baskin E, Besbas N, Gur-Guven A, Kasapcopur O et al (2001) The significance of ANCA in microscopic polyangiitis and classic polyarteritis nodosa. Arch Dis Child 85:427–430CrossRefPubMed
7.
go back to reference Brogan PA, Davies R, Gordon I, Dillon MJ (2002) Renal angiography in children with polyarteritis nodosa. Pediatr Nephrol 17:277–283CrossRefPubMed Brogan PA, Davies R, Gordon I, Dillon MJ (2002) Renal angiography in children with polyarteritis nodosa. Pediatr Nephrol 17:277–283CrossRefPubMed
8.
go back to reference Ozen S (2004) Juvenile polyarteritis: is it a different disease? J Rheumatol 31:831–832PubMed Ozen S (2004) Juvenile polyarteritis: is it a different disease? J Rheumatol 31:831–832PubMed
9.
10.
go back to reference Hartleb M, Biernat L, Kochel A (2002) Drug-induced liver damage—a three-year study of patients from one gastroenterological department. Med Sci Monit 8:CR292–CR296PubMed Hartleb M, Biernat L, Kochel A (2002) Drug-induced liver damage—a three-year study of patients from one gastroenterological department. Med Sci Monit 8:CR292–CR296PubMed
Metadata
Title
Successful treatment of pediatric systemic polyarteritis nodosa with cholestatic hepatitis
Authors
Han-Jung Park
Yong-Jun Choi
Jeong-Eun Kim
Young-Min Ye
Hae-Sim Park
Chang-Hee Suh
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-0121-1

Other articles of this Issue 1/2007

Clinical Rheumatology 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine